New light shed on who benefits most from weight-loss jabs
People who carry variations in two genes linked to appetite and digestion can lose more weight when taking drugs to treat obesity, research suggests.
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
No locations linked to this story
All Coverage
People who carry variations in two genes linked to appetite and digestion can lose more weight when taking drugs to treat obesity, research suggests.
Similar Stories
Related coverage based on topic and tags
New drug to stop 'Ozempic butt' muscle loss side effect of obesity jabs
A third of the weight loss from obesity jabs can come from muscle, say experts.
June 8, 2026 at 03:00 PMWeight-loss drug Wegovy to be available in pill form in UK for first time
Manufacturer Novo Nordisk says a daily tablet of the drug could be more convenient for some people than weekly injections.
June 11, 2026 at 03:00 PMHow do weight-loss drugs like Mounjaro and Wegovy work?
Wegovy and Mounjaro are available to certain patients on the NHS, and can also be bought privately.
June 11, 2026 at 03:03 PMUK approves Novo weight-loss pill to edge open European market - Reuters
UK approves Novo weight-loss pill to edge open European market Reuters
June 11, 2026 at 08:22 PM'I've never been this good' – revolutionary immune reset puts lupus in remission
Patients on the trial have not needed medication to manage their condition.
June 11, 2026 at 11:31 PMCould gut parasites be influencing your behaviour?
Could the parasite also impact human behaviour? Made in partnership with UKRI.
June 4, 2026 at 11:19 AM